| Tag | Content |
|---|
EnhancerAtlas ID | HS161-05823 |
Organism | Homo sapiens |
Tissue/cell | PC3 |
Coordinate | chr16:28935220-28935720 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| STAT3 | MA0144.2 | chr16:28935374-28935385 | TTTCCCAGAAG | - | 6.62 | | Stat4 | MA0518.1 | chr16:28935371-28935385 | CTATTTCCCAGAAG | - | 6.16 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_10806 | chr16:28934105-28937640 | CD19_Primary | | SE_11724 | chr16:28932064-28938989 | CD20 | | SE_54362 | chr16:28934039-28937660 | Spleen | | SE_62078 | chr16:28933981-28957654 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | CAGCTGGGGC GTCTGGGGCC AGAGGACCAA GTACAAAGAA CGTGGGGCGG AGGTGGGGAA 60
GCTGGTGCAT GGCGTGGGGT GGAGGGGGGA GTGTCTGGGG AAGGCTAGAG AGCAGAGCAT 120
TAGACTCACA GAGACTGGGC CAGGGCTGAT TCTATTTCCC AGAAGTCCAG ACTAAAATGA 180
GGTTGGTTTG GGGAACTGAG AAGTTTCTCG CCCATCTTCA GGGTTGATCA ATCATCAGTG 240
AGGGACAAGA AATGACATGG GACAAGGCAA CAGATAGAAG CTGGGAGCTA AACTTAGCTA 300
TAACTGACAG AGCTGCTGCT ATCACATGGA GGGCCTCTAT GCAAATTTTA AAAGGGCGGC 360
CCTTCCTCTG GGCCATAGGC ATGCCCTGTG CCAGGCAGCC CTGCTAACCT ATCCCATAGC 420
TTATCTGTGC CCCCAATCCC TTTCTCGTCA TGCACTCCCC AGTATGGGGT TGATGGGGAG 480
TCTAGGTGAG TCCCGCGTCT 500
|
